Frontlight ResearchEarly access
Colorectal cancer trials in United Kingdom
89 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- London, Manchester
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- London, Newcastle upon Tyne
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Cambridge, London, Middlesex
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1/2Taking peopleHTL0039732 in Participants With Advanced Solid Tumours
- Where
- Cambridge, Cardiff, Dundee, Liverpool, London, Manchester
- Age
- 18 years and over
- People
- 150
- Run by
- Cancer Research UK
See details and how to joinNCT05944237 - Phase 1Taking peopleA Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Where
- Leicester, London, Sutton
- Age
- 18 years and over
- People
- 83 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07277270 · EU 2025-522274-37-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Cambridge, Dundee, London, Manchester
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - No phaseTaking peoplePre-Clinical Validation of ChemoINTEL Unified Algorithm Chemotherapeutic Response Prediction in Patients With Colorectal Cancer
- Where
- Liverpool
- Age
- 18 years and over
- People
- 100
- Run by
- Pierian Biosciences
See details and how to joinNCT07830407 - Phase 1Taking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Chelsea, Oxford, Sutton
- Age
- 18 years and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - No phaseTaking peopleChemo Brain Prehab Project
- Where
- Blackburn, Lancaster, Liverpool, Preston
- Age
- 60 years to 85 years
- People
- 86
- Run by
- Dr. Chris Gaffney
See details and how to joinNCT07341217 - Phase 1Taking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- London, Manchester
- Age
- 12 years to 85 years
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - No phaseTaking peopleNew bioMarkers tO straTIfy cOlorectal caNcer Referrals
- Where
- London
- Age
- 18 years and over
- People
- 582
- Run by
- Queen Mary University of London
See details and how to joinNCT07035691 - Phase 3Taking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Birmingham, Glasgow, London, Maidstone, Northwood, Sheffield, Sutton
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649 - No phaseNot yet taking people in United KingdomSecondary Care Colorectal Cancer Pathway Review
- Where
- Edinburgh
- Age
- 18 years and over
- People
- 25,000
- Run by
- University of Edinburgh
See details and how to joinNCT07430527 - No phaseTaking peopleOptimising Colorectal Cancer Patient Pathways
- Where
- Edinburgh
- Age
- 18 years and over
- People
- 1,000
- Run by
- University of Edinburgh
See details and how to joinNCT07430540 - No phaseNot yet taking people in United KingdomUse of a Novel Camera to Check the Bowel After Polyp or Tumour Removal
- Where
- Edinburgh
- Age
- 16 years and over
- People
- 30
- Run by
- University of Edinburgh
See details and how to joinNCT07341126 - Phase 2/3Taking peopleDETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Where
- Belfast, Birmingham, Bristol, Cambridge, Cardiff, Edinburgh, Glasgow, Leicester, Liverpool, London, Manchester, Metropolitan Borough of Wirral, Newcastle, Oxford, Sheffield, Southampton, Sutton
- Age
- 1 year and over
- People
- 30
- Run by
- Cancer Research UK
See details and how to joinNCT07440290 - Phase 1/2Taking peopleTT-702 in Patients With Advanced Solid Tumours.
- Where
- London, Manchester, Southampton
- Age
- 16 years and over
- People
- 60
- Run by
- Cancer Research UK
See details and how to joinNCT05272709 - Phase 1Taking peopleStudy of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Cambridge
- Age
- 18 years and over
- People
- 307 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT05433142 · EU 2024-513619-28-00 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- London, Sutton
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 1Taking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Edinburgh, London
- Age
- 18 years and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - Phase 1/2Taking peopleA Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- Where
- London, Manchester, Sutton
- Age
- 18 years and over
- People
- 482 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07079631 · EU 2025-521768-36-00 - No phaseTaking peopleClinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients
- Where
- London
- Age
- 18 years and over
- People
- 100
- Run by
- Royal Marsden NHS Foundation Trust
See details and how to joinNCT07673861 - No phaseTaking peoplePostoperative Electrical Muscle Stimulation Two
- Where
- Derby
- Age
- 18 years and over
- People
- 45
- Run by
- University of Nottingham
See details and how to joinNCT06964438 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Glasgow, Leicester, London, Manchester, Oxford
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 1/2CompletedA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- London, Manchester, Sutton
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00